Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Arthritis Research & Therapy|February 22, 2019
Health-related quality of life in patients with giant cell arteritis treated with tocilizumab in a phase 3 randomised controlled trialVibeke Strand, Sophie Dimonaco, Katie Tuckwell, et al.
Annals of the Rheumatic Diseases|October 30, 2015
Tocilizumab in early progressive rheumatoid arthritis: FUNCTION, a randomised controlled trialGerd R Burmester, William F Rigby, Ronald F van Vollenhoven, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|June 10, 2017
Transaminase Levels and Hepatic Events During Tocilizumab Treatment: Pooled Analysis of Long-Term Clinical Trial Safety Data in Rheumatoid ArthritisMark C Genovese, Joel M Kremer, Ronald F van Vollenhoven, et al.
The Pediatric Infectious Disease Journal|June 10, 2020
Baloxavir Marboxil Single-dose Treatment in Influenza-infected Children: A Randomized, Double-blind, Active Controlled Phase 3 Safety and Efficacy Trial (miniSTONE-2)Jeffrey Baker, Stanley L Block, Balpreet Matharu, et al.
Annals of the Rheumatic Diseases|April 9, 2017
Tocilizumab combination therapy or monotherapy or methotrexate monotherapy in methotrexate-naive patients with early rheumatoid arthritis: 2-year clinical and radiographic results from the randomised, placebo-controlled FUNCTION trialGerd R Burmester, William F Rigby, Ronald F van Vollenhoven, et al.
Rheumatology and Therapy|May 13, 2018
Risk Associated with Cumulative Oral Glucocorticoid Use in Patients with Giant Cell Arteritis in Real-World Databases from the USA and UKSara Gale, Jessica C Wilson, Jenny Chia, et al.
Rheumatology (Oxford, England)|December 26, 2016
Effect of tocilizumab on neutrophils in adult patients with rheumatoid arthritis: pooled analysis of data from phase 3 and 4 clinical trialsRobert J Moots, Anthony Sebba, William Rigby, et al.
Seminars in Arthritis and Rheumatism|December 22, 2016
Newly diagnosed vs. relapsing giant cell arteritis: Baseline data from the GiACTA trialKatie Tuckwell, Neil Collinson, Sophie Dimonaco, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|March 6, 2019
Glucocorticoid Dosages and Acute-Phase Reactant Levels at Giant Cell Arteritis Flare in a Randomized Trial of TocilizumabJohn H Stone, Katie Tuckwell, Sophie Dimonaco, et al.
The New England Journal of Medicine|July 27, 2017
Trial of Tocilizumab in Giant-Cell ArteritisJohn H Stone, Katie Tuckwell, Sophie Dimonaco, et al.
Pageof 2